Sakar Healthcare Stock Screener | Share Price & Fundamental Analysis
SAKAR
Pharmaceuticals
Share Price NSE
₹618.60
▲
29.15 (4.95%)
As of April 13, 2026, the Sakar Healthcare share price (NSE: SAKAR) is ₹618.60, up 4.95% from the previous close, with shares trading between ₹578.05 and ₹639.80, and a 52-week range of ₹346.45–₹618.60.
Browse Sakar Healthcare financial data to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sakar Healthcare Market Cap
₹1,376.38 Cr.
SAKAR P/E Ratio (TTM)
51.98
Sakar Healthcare P/B Ratio
4.32
EPS (TTM)
₹7.97
Dividend Yield
-
Debt to Equity
0.30
SAKAR 52 Week High
₹618.60
Sakar Healthcare 52 Week Low
₹346.45
Operating Margin
26.00%
Profit Margin
14.08%
SAKAR Revenue (TTM)
₹71.00
EBITDA
₹19.00
Net Income
₹10.00
Total Assets
₹415.00
Total Equity
₹286.00
Sakar Healthcare Share Price History - Stock Screener Chart
Screen SAKAR historical share price movements with interactive charts. Analyze price trends and patterns.
Sakar Healthcare Company Profile - Fundamental Screener
Screen Sakar Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SAKAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE732S01012
Sakar Healthcare Balance Sheet Screener
Screen SAKAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 415 | 389 | 336 | 268 | 178 | 115 |
| Current Assets | 89 | 72 | 56 | 50 | 34 | 22 |
| Fixed Assets | 309 | 314 | 267 | 205 | 69 | 66 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 67 | 67 | 109 | 94 | 46 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 286 | 262 | 173 | 128 | 99 | 81 |
| Share Capital | 22 | 22 | 19 | 17 | 16 | 15 |
| Reserves & Surplus | 261 | 236 | 154 | 110 | 83 | 66 |
Sakar Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Sakar Healthcare income statement and profit fundamentals.
Analyze SAKAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sakar Healthcare share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71 | 59 | 53 | 50 | 44 | 43 | 42 | 44 | 38 | 35 | 41 | 43 | 35 | 31 | 29 |
| Expenses | 52 | 46 | 40 | 35 | 32 | 31 | 31 | 32 | 28 | 25 | 30 | 33 | 25 | 22 | 21 |
| EBITDA | 19 | 13 | 13 | 16 | 12 | 12 | 11 | 12 | 9 | 10 | 11 | 10 | 11 | 9 | 8 |
| Operating Profit % | 26.00% | 20.00% | 24.00% | 31.00% | 27.00% | 27.00% | 26.00% | 25.00% | 24.00% | 27.00% | 23.00% | 19.00% | 26.00% | 28.00% | 28.00% |
| Depreciation | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 4 |
| Interest | 2 | 2 | 2 | 4 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Profit Before Tax | 11 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 3 | 4 | 4 | 4 | 5 | 4 | 4 |
| Tax | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 3 | 1 |
| Net Profit | 10 | 5 | 5 | 6 | 5 | 5 | 2 | 3 | 2 | 4 | 3 | 4 | 4 | 2 | 3 |
| EPS | 4.59 | 2.03 | 2.11 | 2.66 | 2.08 | 2.17 | 1.10 | 1.46 | 0.98 | 1.68 | 1.46 | 2.04 | 2.16 | 1.01 | 1.65 |
Sakar Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SAKAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 34 | 25 | 33 | 36 | 15 | 19 |
| Investing Activities | -31 | -52 | -74 | -90 | -47 | -22 |
| Financing Activities | -4 | 27 | 41 | 55 | 32 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
Sakar Healthcare Shareholding Pattern Screener
See Sakar Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Sakar Healthcare promoter holding and ownership changes for SAKAR on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.86% | 52.86% | 52.86% | 53.58% | 53.58% | 53.15% | 53.15% | 53.15% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 11.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.59% | 16.01% | 15.86% | 15.93% | 15.75% | 16.88% | 16.80% | 16.78% |
| Other Holding | 19.20% | 31.13% | 31.28% | 30.48% | 30.67% | 29.97% | 30.05% | 30.07% |
| Shareholder Count | 7,069 | 7,565 | 8,115 | 8,608 | 8,598 | 7,867 | 7,313 | 7,386 |
Sakar Healthcare Share Dividend Screener - Share Yield Analysis
Check Sakar Healthcare dividend history with payout and yield data.
View Sakar Healthcare dividend details including ex-dates and amounts for SAKAR stock.
Sakar Healthcare Stock Index Membership
See which indices include Sakar Healthcare stock.
Check SAKAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sakar Healthcare Market Events Screener - Corporate Actions
Get Sakar Healthcare corporate actions including splits, bonuses, and buybacks.
Check Sakar Healthcare stock events that may affect SAKAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -2.20% | ||
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 5.67% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | 8.00% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 15.50% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 0.83% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | -0.03% |
| 2023-12-20 | 2023-12-20 | Extraordinary General Meeting | NA | -5.45% |
Sakar Healthcare Competitors Screener - Peer Comparison
Screen SAKAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 396,418 | 36.25 | 54,729 | 9.71% | 10,980 | 33.68 |
| Divis Laboratories | 161,139 | 65.53 | 9,712 | 18.67% | 2,191 | 50.76 |
| Torrent Pharmaceuticals | 141,504 | 61.93 | 11,539 | 6.99% | 1,911 | 49.76 |
| Lupin | 105,810 | 22.84 | 22,910 | 13.74% | 3,306 | 53.72 |
| Dr Reddys Laboratories | 103,154 | 18.62 | 33,741 | 16.73% | 5,725 | 46.43 |
| Cipla | 97,830 | 21.91 | 28,410 | 7.12% | 5,291 | 36.48 |
| Zydus Life Science | 92,815 | 18.33 | 23,511 | 18.55% | 4,615 | 59.14 |
| Mankind Pharma | 85,756 | 47.59 | 12,744 | 20.90% | 2,007 | 51.41 |
| Aurobindo Pharma | 77,816 | 22.50 | 32,346 | 9.43% | 3,484 | 62.63 |
| Alkem Laboratories | 64,141 | 26.85 | 13,458 | 3.70% | 2,216 | 49.73 |
Sakar Healthcare Company Announcements - News Screener
Screen SAKAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-08 | General Updates | - |
| 2026-03-24 | Trading Window | - |
| 2026-02-19 | Reply to Clarification- Financial results | - |
| 2026-02-17 | Clarification - Financial Results | - |
| 2026-02-17 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-02-11 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-02-10 | Investor Presentation | - |
| 2026-02-07 | Press Release | - |
| 2026-02-07 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-02-07 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-02-05 | Outcome of Board Meeting | - |
| 2026-02-05 | Outcome of Board Meeting | - |
| 2026-01-30 | General Updates | - |
| 2026-01-20 | Reply to Clarification- Financial results | - |
| 2026-01-12 | Clarification - Financial Results | - |
| 2026-01-10 | General Updates | - |
| 2025-12-22 | Trading Window | - |
| 2025-12-19 | General Updates | - |
| 2025-11-17 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2025-11-11 | Press Release | - |